{"disease":{"id":"endocarditis-infective","name":"endocarditis infective"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06957119","title":"Prognosis and Management of Infective Endocarditis Using the Clinical Data Warehouse From AP-HP","phase":"","overall_status":"COMPLETED","enrollment_count":3000,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05061355","title":"Antibiotics Vs Antibiotics and Surgical ThERapy for Infective Endocarditis","phase":"NA","overall_status":"RECRUITING","enrollment_count":496,"lead_sponsor_name":"Emil Loldrup Fosbol","has_results":false},{"nct_id":"NCT07346222","title":"San Matteo Endocarditis Registry STEADY","phase":"","overall_status":"RECRUITING","enrollment_count":418,"lead_sponsor_name":"Fondazione IRCCS Policlinico San Matteo di Pavia","has_results":false},{"nct_id":"NCT05398679","title":"Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":360,"lead_sponsor_name":"Fundacion Clinic per a la Recerca Biomédica","has_results":false},{"nct_id":"NCT05037474","title":"Contemporary Transvenous Lead Extraction Outcomes","phase":"","overall_status":"UNKNOWN","enrollment_count":340,"lead_sponsor_name":"Deutsches Herzzentrum Muenchen","has_results":false},{"nct_id":"NCT06423898","title":"Ampicillin and Ceftriaxone for the Treatment of Enterococcus Faecalis Infective Endocarditis.","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":284,"lead_sponsor_name":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","has_results":false},{"nct_id":"NCT05791357","title":"The Role of Polymerase Chain Reaction in the Management of Patients With Infective Endocarditis","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT00695903","title":"Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":38,"lead_sponsor_name":"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","has_results":true},{"nct_id":"NCT05329168","title":"ERAdicate S. Aureus in Patients With Bacteremia and Endocarditis","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Lysovant","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}